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The SH-SY5Y culture system is a convenient neuronal model with the potential to
elaborate human/primate-specific transcription networks and pathways related to human
cognitive disorders. While this system allows for the exploration of specialized features
in the human genome, there is still significant debate about how this model should
be implemented, and its appropriateness for answering complex functional questions
related to human neural architecture. In view of these questions we sought to characterize
the posttranscriptional regulatory structure of the two-stage ATRA differentiation, BDNF
maturation protocol proposed by Encinas et al. (2000) using integrative whole-genome
gene and microRNA (miRNA) expression analysis. We report that ATRA-BDNF induced
significant increases in expression of key synaptic genes, brain-specific miRNA and
miRNA biogenesis machinery, and in AChE activity, compared with ATRA alone. Functional
annotation clustering associated BDNF more significantly with neuronal terms, and with
synaptic terms not found in ATRA-only clusters. While our results support use of SH-SY5Y
as a neuronal model, we advocate considered selection of the differentiation agent/s
relative to the system being modeled.
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INTRODUCTION
The nervous system, and in particular the brain, arguably repre-
sents the most complex area of human biology. Many different
cell types are present, interacting in multiplexed combinations,
and every circuit is uniquely wired by individual patterns of
experience. This complexity continues down to the subcellu-
lar level with intricate transportation systems and biomolecular
partitioning. Temporo-spatial specificity of mRNA translation in
particular is critical for localized protein synthesis as it supports
the synaptic remodeling required for synaptic plasticity.
Recent studies have suggested that small, non-coding RNA
species known as microRNA (miRNA) play a role in supporting
temporo-spatial traffic of neuronal mRNA (Goldie and Cairns,
2012). Many miRNA demonstrate brain-specific (Smirnova et al.,
2005; Krichevsky et al., 2006) and region-specific (Hollins et al.,
2014) expression and have been shown to regulate key aspects
of brain development and neuronal morphology (Giraldez et al.,
2005), including patterning and arealisation, dendritic branching
(Xu et al., 2008) and spine volume (Schratt et al., 2006). The pres-
ence of miRNA in exosomes suggests they may also play a role in
activity-driven communication (Fauré et al., 2006).
A key limitation in studies of the nervous system is that ethi-
cal considerations and availability of tissue generally restrict these
investigations to animal models, relying on in-vitro or ex-vivo
preparations, typically of mouse or rat, to extrapolate human
function. Although the composition of the post-synaptic den-
sity is well conserved among mammals (Bayés et al., 2010), the
dynamic component of plasticity provided bymRNA andmiRNA
is quite divergent. Human transcription networks have evolved
a complexity that drives species-specific gene expression in the
pre-frontal (PFC) and frontal cortices (Konopka et al., 2012).
Among transcripts that are subject to human-specific develop-
mental remodeling, miRNA in the PFC exhibit the greatest and
most rapid divergence from other primates with an average evo-
lutionary length 24 times that of other transcript types (Somel
et al., 2011). These findings suggest that animal models, while
informative, may not provide full understanding of the molecu-
lar mechanisms underlying neuronal function in higher primates
and humans.
NEURONAL DIFFERENTIATION OF NEUROBLASTOMAS
To overcome this limitation, several human immortalized cell
lines are available which for some purposes can model human
neuron behavior. Among these, neuroblastoma cell lines are
highly accessible and can be matured into terminally differenti-
ated, neuron-like cells using agents such as retinoic acid (RA),
enabling clearer determination of molecular and morphological
changes induced by differentiation. Treatment with RA is asso-
ciated with inhibition of proliferation, extension of processes
commonly termed neurites (Stio et al., 2001), increased acetyl-
cholinesterase (AChE) activity (Sidell et al., 1984), and enhanced
production of synaptic vesicles (Sarkanen et al., 2007); features
consistent with neuronal maturation.
In the SH-SY5Y cell line, a sympathetic line containing nora-
drenaline and neuropeptide Y in dense-core vesicles (Goodall
et al., 1997; Ou et al., 1998), three stereoisomers of RA, all-trans
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(ATRA), 9-cis and 13-cis, are all observed to induce this pheno-
type, however differential activity at the receptor level appears
to impact the differentiation process. ATRA acts at the native
retinoic acid receptor (RAR), which binds to retinoic acid
response elements (RAREs) in the DNA to alter transcription
of RA-activated genes, while the 9-cis isomer acts in a similar
manner on the retinoid X receptor (RXR). This difference could
explain the observation that although 9-cis RA induces stronger
morphological and transcriptional responses these changes are
reversed after washout, while the response to ATRA is permanent
(Redfern et al., 1994). This finding suggests that ATRA may be a
more suitable agent for studying the effects of commitment to a
neuronal lineage.
NEURONAL MATURATIONWITH BDNF
In the developing brain, the final connectivity of a neuron is
determined largely by signals received from the neurotrophin
family of proteins, which are expressed in a laminar-specific
pattern and influence the growth and complexity of the den-
dritic tree (McAllister et al., 1995). Of this family, brain-derived
neurotrophic factor (BDNF) has a profound effect on pyrami-
dal neurons in cortical layers 4 and 5, in addition to which it
has demonstrated the capacity to target mRNAs to the synapse
(Tongiorgi et al., 1997; Righi et al., 2000) and stimulate their local
translation (Miyata et al., 2005). In particular, polysome pro-
filing of active translation conducted by Schratt and colleagues
demonstrated that BDNF is required to stimulate local translation
of key synaptic components such as CamKII, NMDA receptors
NR1, and NR3, PSD93 and LIMK-1 (Schratt et al., 2004). These
findings suggest the employment of BDNF for in vitro neu-
ronal maturation may produce cells more closely matching the
phenotype and, importantly, gene expression profile of neurons
in vivo.
BDNF is active at the trkB receptor (gene name NTRK2),
which is absent from naïve SH-SY5Y cells; its expression can be
induced by differentiation with ATRA (Kaplan et al., 1993), and
some studies have employed a 5–6 day protocol of concurrent
ATRA and BDNF treatments. However, in an arguably seminal
paper published in 2000, Encinas and colleagues demonstrated
that trkB does not reach peak expression in this cell line until 5
days’ exposure to ATRA (Encinas et al., 2000); thus these short-
duration, dual-agent protocols may bear limited similarity to
mature neurons: a model of sequential treatment with ATRA for
5 days followed by BDNF, that yields neurotrophin-dependent
mature cells, may be more physiological.
RATIONALE AND METHODS
We performed a comprehensive review of the literature to
understand the use of differentiation protocols for the matu-
ration of SH-SY5Y cells. Specifically, for in vitro research work
attempting to emulate mature neuronal behavior, we wanted
to know to what extent the sequential treatment with ATRA
followed by BDNF was being utilized compared with other dif-
ferentiation protocols or undifferentiated cells. A search of the
PubMed literature for “SH-SY5Y” identified 3419 papers pub-
lished in English between the publication of the Encinas protocol
(2000) and the time of writing (April 2014), from which 410
papers studying the neuroblastoma disease itself were excluded.
This list was narrowed to 2307 papers by searching for words
associated with differentiation, neurodegeneration and mental
health conditions (see Supplementary Figure S1 for full descrip-
tion of review inclusion/exclusion criteria). Surprisingly, 1914
of 2307 papers (83%) did not utilize a differentiation protocol
at all, nor was an explanation for using undifferentiated cells
given.
Among 393 studies employing a differentiation protocol, the
most common differentiation agent was ATRA only (283 of 393
papers, 72%, or 12% of all studies); approximately 16% (65
papers, 3% of all studies) utilized other differentiating agents
such as the phorbolester 12-O-tetradecanoylphorbol-13-acetate
(TPA), which has been shown to generate an adrenergic phe-
notype (Påhlman et al., 1983). Moreover, a remarkably small
proportion (45 papers, 11 or 2% of all studies) utilized Encinas’
sequential protocol of ATRA differentiation followed by BDNF,
despite its compelling evidence: The switch from ATRA to
BDNF on day 5 coincides with peak expression of its recep-
tor trkB, however the biochemical impact of this transition
has not previously been reported, nor has the gene expression
profile been extensively characterized. Moreover, the impor-
tance of post-transcriptional regulation of gene expression by
miRNA in the control of neuronal differentiation, development,
connectivity, and synaptic function is now well established, as
reviewed in Goldie and Cairns (2012); a thorough investiga-
tion of this two-stage neuronal model in this light is therefore
timely.
We undertook comparative genome-wide gene and miRNA
expression analyses of naïve, 5-day ATRA-treated and 5-day
ATRA- + 7-day BDNF-treated SH-SY5Y using Affymetrix Exon
v1.0 and miRNA v2.0 microarrays. Data were analyzed with
Genespring Gx 12 software (Agilent) to identify differen-
tially expressed transcripts with Benjamini-Hochberg correction
for multiple testing and a corrected p-value cut-off of 0.05.
Microarray results were confirmed by examination of a selec-
tion of significantly altered transcripts by qPCR with random-
primed cDNA for gene expression and specific mature miRNA
primers for miRNA expression as described previously (Santarelli
et al., 2011). Functional analysis of gene expression changes was
conducted using the Functional Annotation Clustering (FAC)
tool of the DAVID bioinformatics suite (Huang et al., 2008)
on lists of genes having significantly different expression (as
defined above) at each timepoint. Integrated analysis of altered
miRNA expression was conducted using QIAGEN’s Ingenuity
Pathways Analysis software (IPA, QIAGEN Redwood City, www.
qiagen.com/ingenuity). A target analysis was performed on sig-
nificantly up- and down-regulated miRNA, and the list of tar-
gets refined by expression pairing with the list of altered genes.
Core analysis was carried out on negatively correlated pair-
ings to investigate significantly altered pathways and functional
networks.
To report on biochemical neuronal maturity, we measured
the acetylcholinesterase (AChE) activity of samples collected at
various timepoints during differentiation and maturation using
the Amplex Red AChE assay kit according to the manufacturer’s
instructions (Invitrogen).
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SEQUENTIAL DIFFERENTIATION WITH ATRA THEN BDNF
YIELDS A MORE NEURONAL CELL POPULATION
MORPHOLOGY
Neuroblast cultures were imaged at each stage of treatment at
10X magnification with an Axiovert inverted microscope (Zeiss)
(Figure 1). In line with the results of Encinas and colleagues, cells
visually appearedmore neural across the two-stage differentiation
process. Compared with naïve cells (Figure 1A), cells treated with
ATRA for 5 days appeared to have reduced proliferation, took
on a more polar morphology and began to extend longer, more
robust neurites (Figure 1B). During 7 days subsequent BDNF
exposure, cell bodies began to migrate into clusters, some a large
as ∼110μm diameter, while neurites increased in number, size
and complexity (Figure 1C).
GENE EXPRESSION
Differentiation with ATRA significantly altered the expression of
46 genes; remarkably, 38 of these were up regulated, character-
izing neuronal differentiation as the “switching on” of a genetic
programme. BDNF maturation had a much bigger effect on gene
expression, significantly altering 265 genes (189 up, 76 down)
compared with controls and, importantly, 387 genes (123 up, 264
down) compared with ATRA differentiated samples. As shown in
Figure 1D, the genes most strongly induced by ATRA were down
regulated by BDNF maturation, while a group showing only
mild ATRA induction were further strengthened by BDNF. These
included many neuronal genes and components of the miRNA
biogenesis machinery (Table 1A), a panel of which were validated
by qPCR (Figure 1F). Strikingly, neuropeptide Y (NPY), which
has been reported as non-responsive to ATRA (Påhlman et al.,
1995), demonstrated 146-fold increase in expression in response
to sequential ATRA + BDNF.
Genes “activated” by each of the ATRA differentiation and
BDNF maturation processes were functionally analyzed using
the DAVID FAC tool. In ATRA-treated samples the only cluster
terms to remain significant after p-value correction related
to retinoid metabolism. This is perhaps not surprising given
the subsequent down regulation of genes induced by ATRA
treatment. In contrast, when compared with both control and
ATRA-treated cohorts, BDNF-matured samples were strikingly
enriched for neuronally relevant clusters including “neuron
projection” (ES = 4.83, corrected p = 0.00027) and “synaptic
transmission” (ES = 2.33, corrected p = 0.03). Although some
of these terms were present in the ATRA results, they were not
significant (Table 1B).
miRNA EXPRESSION
In response to ATRA differentiation, 36 miRNA demonstrated
significantly different expression. Unlike gene expression there
was no clear directional bias with 20 up and 16 down regulated.
Also in contrast to the gene expression results, the miRNA most
strongly induced by ATRA were further strengthened by BDNF
maturation (Figure 1E). BDNF induced differential expression of
70 miRNA compared to undifferentiated cells (42 down, 28 up).
Notably, differentiation dramatically increased the expression of
miR-132, a key regulator of dendritic growth and arborisation,
as well as known brain-specific miRs –210 and –212, the latter
of which inhabits a locus with miR-132. Significant increase in
expression of miRs –132 and –212 by BDNFmaturation was con-
firmed by qPCR (Figure 1F). We also observed ATRA-mediated
decrease in miR-17 family expression, consistent with previous
observations (Beveridge et al., 2009); all members of this family
were further down-regulated by BDNF maturation.
FUNCTIONAL INTEGRATION
The importance of BDNF in shaping the regulatory environ-
ment of matured cells was investigated using IPA software.
Genes showing two-stage activation (173 genes, Figure 1E, red
line) were paired with a target analysis of 44 negatively corre-
lated miRNA (10 miRNA with 42 target genes). Core analysis
of these molecules showed a strong enhancement of neuronal
functionality, with top functional terms “neurotransmission”
(p = 1.97e-07, APP, GRIK2, KCNMB4, PCDHB10, PCDHB14,
PCDHB5, PSEN1), “neurological disease” (p = 7.41e-07, APP,
BCL2, CHGB, DPYSL3, ESRRG, GABRA3, GRIK2, LGR5,
NTRK2, PLK2, PSEN1, SCN3A, VCAN), “synaptic transmis-
sion of cells” (p = 1.52e-06, APP, GRIK2, PCDHB10, PCDHB14,
PCDHB5, PSEN1), and “synaptogenesis” (p = 1.93e-06, APP,
PCDHB10, PCDHB14, PCDHB5). Full results are presented in
Supplementary Table S1. Visual representation of this analysis
revealed that many of these genes encode proteins that reside in
the synaptic membrane (Supplementary Figure S2). Moreover,
four families of miRNA (miR-18a,b, miR-17,20a,b, miR-130,
and miR-1275) were found to be key hubs providing regulatory
support to this functionality.
ACETYLCHOLINESTERASE ACTIVITY
Only modest changes in AChE activity were observed during
ATRA-induced differentiation, however maturation with BDNF
caused sharp increases in activity (Figure 1G). Strikingly, AChE
activity in cells treated with ATRA for 5 days followed by 1 day of
BDNF exposure was higher than in those treated for 7 days with
ATRA alone, highlighting the importance of the neurotrophin in
development of the neuronal phenotype. Moreover, the magni-
tude of the response increased with ATRA concentration used
to induce differentiation (Supplementary Figure S3), possibly
due to the expression of more BDNF receptors at higher ATRA
concentrations.
DISCUSSION
Human neuroblast cultures, particularly the SH-SY5Y line, are
used extensively to model the basic biology of neurons. They
may also have application in high-throughput screening assays of
neuroactive compounds. The literature is controversial regarding
the need to differentiate SH-SY5Y, as exemplified by an exchange
between Luchtman and Song (2010) regarding the latter’s conclu-
sions with respect to the applicability of SH-SY5Y differentiation
in studying neurotoxicity and neuroprotection in Parkinson’s dis-
ease (Cheung et al., 2009). What is clear from this exchange is the
need to carefully consider experimental methodology and appli-
cability of the cell model used within the context of the research
question.
Our results presented here suggest that the sequential
ATRA differentiation-BDNF maturation program yields a cell
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FIGURE 1 | Comparison of single-stage (ATRA) and two-stage
(ATRA+BDNF) differentiation of SH-SY5Y. Compared with (A) 5DIV
untreated cultures, cells (B) treated with ATRA for 5 days demonstrate
reduced proliferation and take on a more polar appearance, with neurites
being extended and networks beginning to develop. (C) After further
maturation with BDNF, cell bodies migrate into clusters and the neurite
networks become increasingly complex. (D) Heat map (k-means, 4 clusters)
clustering genes and miRNA significantly differentially expressed (blue = low
expression, yellow = high) during sequential differentiation. C = control,
R = ATRA, B = BDNF. Four clusters reveal key expression patterns, in
particular the strength of BDNF induction (star). These are summarized as
trend lines showing average expression of constituent (E) genes and (F)
miRNA; the groups of transcripts demonstrating two-stage induction (red
lines) clustered significantly for neuronal functional terms (see Table 1A) and
contained many key neuronal peptides, receptors and miRNA (see Table 1B).
(Continued)
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FIGURE 1 | Continued
Symbols delineate differing two-stage expression patterns. (G) A selection of
these transcripts examined by qPCR confirmed that maturation with BDNF
drove increased expression (red bars) compared with ATRA differentiation
alone (black bars). ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. (H) AChE activity was
measured after 1, 3, 5, and 7 days’ ATRA treatment, or 5 days’ ATRA treatment
followed by 1, 3 or 5 days’ treatment with BDNF. Increases in AChE activity
were most strongly elicited by BDNFmaturation; notably, 5 day ATRA + 1 day
BDNF evoked more response than an extended 7 day ATRA treatment (red
box). Treatments were 10μMATRA and 50ng/ml BDNF throughout.
Table 1A | Neuronal genes and miRNA demonstrating increased
expression after BDNF maturation of ATRA-differentiated SH-SY5Y.
Gene symbol Gene name Fold-change
(BDNF/ATRA)
NPYa,c Neuropeptide Y 146
RELNa,b,d,e Reelin 9.01
NTRK2b,d Neurotrophic tyrosine kinase, receptor,
type 2
2.0
GRIK3a,d,f Glutamate receptor, ionotropic, kainate 3 3.3
GRIN2Ba,b,c,d Glutamate receptor, NMDA, subunit 2B 3.28
CHRM1a,b Cholinergic receptor, muscarinic 1 3.23
HTR3Ca Serotonin receptor 3C 3.28
HTR5Aa,d,e Serotonin receptor 5A 3.3
DRD2a,c,f Dopamine receptor D2 3.3
HCRTR1d,e Hypocretin (orexin) receptor 1 3.1
CACNA1Ca,b,d,e Calcium channel, voltage-dependent, 1C
subunit
3.3
NRG1a,b,d Neuregulin 1 3.25
DICER1 Dicer 1, ribonuclease type III 2.56
DROSHAa Drosha, ribonuclease type III 2.94
DGCR8a DiGeorge syndrome critical region gene 8 3.04
XPO5 Exportin 5 3.48
MIR132 Hsa-miR-132 3.04
MIR212 Hsa-miR-212 1.78
Disease associations:
aschizophrenia.
bAlzheimer.
cHuntington’s.
dbipolar/mood disorders.
eautism spectrum disorders
f Parkinson’s.
population with significantly more characteristics of mature neu-
rons compared with ATRA treatment alone. We observed obvious
morphological similarities with neurons, including intricate and
complex neurite structure and evidence of migration with cell
bodies organizing into clusters. The cells also displayed sub-
stantial enhancement of neuron-associated gene expression, in
particular induction of NPY, NTRK2, and CHRM2. There was
also evidence of increased posttranscriptional regulation, with
elevated expression of miRNA biogenesis machinery including,
DROSHA, DGCR8, DICER, and XPO5. This capacity was real-
ized through significantly elevated expression of many miRNA,
including key neuronal miRs –132 and –212, supporting the crit-
ical roles these molecules play in developing and mature neurons.
These individual findings were corroborated at the systems level
by the abundance of terms related to neuronal operation and
synapse formation derived from the integrated functional anal-
ysis. Moreover we have recently shown that miRNA expression
and distribution in these cells is rapidly altered in response to
Table 1B | Comparison of significance of neuronal terms derived from
functional clustering of genes altered by sequential differentiation
and maturation of SH-SY5Y.
Term Corrected p-value
ATRA vs. BDNF vs. BDNF vs.
CTRL CTRL ATRA
Neuron development 0.238 0.037 5.19E-03
Neuron differentiation 0.397 3.05E-03 6.24E-03
Axon 0.557 3.04E-05 0.019
Axonogenesis 0.750 0.046 2.40 E-03
Cell morphogenesis involved in
neuron differentiation
0.763 0.066 2.31 E-03
Neuron projection 0.769 2.52E-05 2.65E-04
Neuron projection development 0.812 0.065 3.94E-03
Synaptic transmission n/a 1.25E-04 0.031
Synapse n/a 7.92E-05 0.079
potassium-induced depolarisation (Goldie et al., 2014). A sub-
stantial component of this depolarisation-associated change in
miRNA was found to be mediated by release of miRNA-enriched
exosomes.
These higher orders of neural differentiation and function
are dependent on neurotrophin signaling. The importance of
BDNF and the expression of the trk receptors in shaping the neu-
ronal specialization have been demonstrated from development
through maturity and plasticity. In particular, during cortical
development this neurotrophin exerts profound effects on layer
4 and 5 neurons, where it significantly increases the number and
complexity of dendritic branches (McAllister et al., 1995), axonal
length (Labelle and Leclerc, 2000), as well as the number of spines
(Bamji et al., 2006) and therefore potential synaptic connectiv-
ity. BDNF maturation of SH-SY5Y clearly reproduced this effect
in terms of neurite morphology; however it is generally consid-
ered that these cells do not form synapses. Studies in neurons
have shown that the trkB receptor is required for synapse forma-
tion, and ablation of trkB resulted in deficits of synapse formation
(Luikart et al., 2005). Further, the interaction between BDNF and
the trkB receptor plays an important role in neuronal develop-
ment (Cheng et al., 2011; Dong et al., 2012), and is important for
synaptic plasticity (Kang et al., 1996).
Our systematic review revealed only 2% (45 of 2307) of papers
used sequentially differentiated cells, and only 35 of these studies
allowed sufficient exposure to ATRA (5 days) to allow for maxi-
mal expression of trkB. Without the interaction between BDNF
and trkB, which is optimally induced by exposing the cells to
ATRA for 5 days, synapse formation is unlikely and has not been
reported in conventional culture. However, by pre-treating these
cells with ATRA, Agholme and colleagues were able to detect
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synaptic structures and vesicular transport in a 3D gel matrix cul-
ture. Synapses were found in samples matured in BDNF alone,
however were more numerous whenmatured with a cocktail con-
taining BDNF, neuregulin β1, nerve growth factor and vitamin
D3 (Agholme et al., 2010). Although more work needs to be done
to fully characterize these structures, this finding indicates that
with more development this culture technique may provide a sys-
tem for unraveling some of the complexities of the human neuron
maturation and connectivity.
CONCLUSIONS
SH-SY5Y is a flexible culturing system that can be differentiated
into several mature neuronal phenotypes, depending on the dif-
ferentiation agent selected. In our investigation of gene expression
and the posttranscriptional regulatory environment of these cells,
we found that differentiation combined with BDNFmaturation is
optimal for generating a phenotype approachingmature neurons.
By contrast, the changes induced by ATRA alone appeared to pro-
duce an intermediate phenotype between immature neuroblasts
and mature neurons, and may be a suitable analog for the study
of developing neurons. This system provides a robust in vitro
alternative to animal models for investigating some aspects of
neuronal function with the advantage of the human genetic
context for revealing species-specific higher order complexity.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://www.frontiersin.org/journal/10.3389/fncel.2014.
00325/abstract
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